Cargando…
The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
This study aimed to explore the role and mechanism of felodipine in lung cancer therapy. Murine subcutaneous lung squamous cancer (LUSC) models constructed by KLN-205 cells were utilized to assess the effect of felodipine monotherapy and in combination with the programmed cell death protein 1 antibo...
Autores principales: | Liang, Si-Yu, Xiao, Hong-Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518203/ https://www.ncbi.nlm.nih.gov/pubmed/37750075 http://dx.doi.org/10.1515/med-2023-0801 |
Ejemplares similares
-
NF-YA Overexpression in Lung Cancer: LUSC
por: Bezzecchi, Eugenia, et al.
Publicado: (2019) -
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
por: Yi, Ming, et al.
Publicado: (2019) -
Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
por: Zhu, Shaoming, et al.
Publicado: (2021) -
The Synergistic Effect of Immune Checkpoint Blockade and Radiotherapy in Recurrent/Metastatic Sinonasal Cancer
por: Yazici, Gozde, et al.
Publicado: (2018) -
Nanovesicles for transdermal delivery of felodipine: Development, characterization, and pharmacokinetics
por: Yusuf, Mohd, et al.
Publicado: (2014)